← All trials
NCT04250519
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 15, 2020
- Primary completion
- Feb 15, 2020
- Completion date
- Apr 15, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 150
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tamil Nadu Dr.M.G.R.Medical UniversityLead sponsor
- Tamil Nadu Dr.M.G.R.Medical UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.